Zephyrx will combine FeNO by Niox into the Zephyrx Respiratory Cloud Platform to advance scientific analysis, in keeping with a joint press launch.
Zephyrx has shortly change into an business chief in respiratory monitoring options for hybrid scientific analysis. In working with sponsors, Zephyrx and Niox acknowledged a necessity for a extra seamless answer by integrating FeNO by Niox measurements into the Zephyrx platform. Niox, the world chief in FeNO testing, is the associate of alternative for Zephyrx to additional develop its providing for scientific analysis.
“We’re thrilled to launch this growth to our platform and have already seen an impression on the scientific trials we’re supporting. Our purpose is to be that single supply of reality for varied endpoints utilized in respiratory analysis, and we’ve got extra integrations deliberate for 2024”, stated Michael DiCesare, Zephyrx President and Cofounder.
Tom Scaccia, Niox Sr. Vice President, Americas and Analysis Enterprise, provides “Niox Vero is the world chief in FeNO testing and we’re excited to be a associate with Zephyrx as they develop their platform capabilities.”
Measurements from the NIOX gadget are captured within the Zephyrx Respiratory Cloud Platform and accessible in real-time by the Supplier Dashboard. Zephyrx just lately launched a brand new function enabling researchers to see all endpoints in a single view, with historic knowledge trending and participant adherence monitoring. Sponsors can even use this function to observe examine web site efficiency, enabling well timed intervention for improved examine outcomes.
